Caribou Biosciences Inc
NASDAQ:CRBU 1:27:08 PM EDT
| Market Cap (Intraday) | 340.48M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $4.00 |
| 50-Day MA | $5.62 |
| 200-Day MA | $5.62 |
Caribou Biosciences Inc Stock, NASDAQ:CRBU
2929 7th Street, Suite 105, Berkeley, California 94710
United States of America
Phone: +1.510.982.6030
Number of Employees: 158
Description
Caribou Biosciences, Inc. engages in the development of an internal pipeline of off-the-shelf CAR-T and CAR-NK cell therapies. Its tools and technologies provide transformative capabilities to basic and applied biological research, therapeutic development, agricultural biotechnology, and industrial biotechnology. The company was founded by Jennifer A. Doudna, Rachel E. Haurwitz, Martin Jinek and James Berger on October 28, 2011 and is headquartered in Berkeley, CA.